These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7993983)

  • 1. The absence of a pharmacokinetic interaction between aspirin and the angiotensin-converting enzyme inhibitor benazepril in healthy volunteers.
    Sioufi A; Pommier F; Gauducheau N; Godbillon J; Choi L; John V
    Biopharm Drug Dispos; 1994 Aug; 15(6):451-61. PubMed ID: 7993983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of hepatic cirrhosis on the pharmacokinetics of benazepril hydrochloride.
    Kaiser G; Ackermann R; Gschwind HP; James IM; Sprengers D; McIntyre N; Defalco A; Holmes IB
    Biopharm Drug Dispos; 1990 Dec; 11(9):753-64. PubMed ID: 2271751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disposition of [14C]-labelled benazepril HCl in normal adult volunteers after single and repeated oral dose.
    Waldmeier F; Kaiser G; Ackermann R; Faigle JW; Wagner J; Barner A; Lasseter KC
    Xenobiotica; 1991 Feb; 21(2):251-61. PubMed ID: 2058180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic/pharmacodynamic modeling of benazepril and benazeprilat after administration of intravenous and oral doses of benazepril in healthy horses.
    Serrano-Rodríguez JM; Gómez-Díez M; Esgueva M; Castejón-Riber C; Mena-Bravo A; Priego-Capote F; Ayala N; Caballero JMS; Muñoz A
    Res Vet Sci; 2017 Oct; 114():117-122. PubMed ID: 28371693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic/pharmacodynamic modelling of the disposition and effect of benazepril and benazeprilat in cats.
    King JN; Maurer M; Toutain PL
    J Vet Pharmacol Ther; 2003 Jun; 26(3):213-24. PubMed ID: 12755906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of benazepril hydrochloride in patients with major proteinuria.
    Schweizer C; Kaiser G; Dieterle W; Mann J
    Eur J Clin Pharmacol; 1993; 44(5):463-6. PubMed ID: 8359184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of the angiotensin-converting-enzyme inhibitor, benazepril, and its active metabolite, benazeprilat, in dog.
    King JN; Maurer M; Morrison CA; Mauron C; Kaiser G
    Xenobiotica; 1997 Aug; 27(8):819-29. PubMed ID: 9293618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous determination of benazepril hydrochloride and benazeprilat in plasma by high-performance liquid chromatography/electrospray-mass spectrometry.
    Xiao W; Chen B; Yao S; Cheng Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(2):303-8. PubMed ID: 15639452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of the active metabolite of benazepril, benazeprilat, and inhibition of plasma angiotensin-converting enzyme activity after single and repeated administrations to dogs.
    King JN; Mauron C; Kaiser G
    Am J Vet Res; 1995 Dec; 56(12):1620-8. PubMed ID: 8599524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between furosemide and the converting enzyme inhibitor benazepril in healthy volunteers.
    De Lepeleire I; Van Hecken A; Verbesselt R; Kaiser G; Barner A; Holmes I; De Schepper PJ
    Eur J Clin Pharmacol; 1988; 34(5):465-8. PubMed ID: 3203706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma angiotensin converting enzyme activity and pharmacokinetics of benazepril and benazeprilat in cats after single and repeated oral administration of benazepril.HCl.
    King JN; Humbert-Droz E; Maurer M
    J Vet Pharmacol Ther; 1999 Dec; 22(6):360-7. PubMed ID: 10651464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of the ace inhibitor benazepril hydrochloride in the elderly.
    Kaiser G; Ackermann R; Dieterle W; Durnin CJ; McEwen J; Ghose K; Richens A; Holmes IB
    Eur J Clin Pharmacol; 1990; 38(4):379-85. PubMed ID: 2344861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of benazepril relative to other ACE inhibitors.
    Gengo FM; Brady E
    Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV44-50; discussion IV51-5. PubMed ID: 1893642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An angiotensin converting enzyme inhibitor, benazepril can be transformed to an active metabolite, benazeprilat, by the liver of dogs with ascitic pulmonary heartworm disease.
    Kitagawa H; Ohba Y; Kuwahara Y; Ohne R; Kondo M; Nakano M; Sasaki Y; Kitoh K
    J Vet Med Sci; 2003 Jun; 65(6):701-6. PubMed ID: 12867730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic interaction study between benazepril and amlodipine in healthy subjects.
    Sun JX; Cipriano A; Chan K; John VA
    Eur J Clin Pharmacol; 1994; 47(3):285-9. PubMed ID: 7867683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of renal insufficiency on the pharmacokinetics and pharmacodynamics of benazepril in cats.
    King JN; Strehlau G; Wernsing J; Brown SA
    J Vet Pharmacol Ther; 2002 Oct; 25(5):371-8. PubMed ID: 12423228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of the angiotensin converting enzyme inhibitor benazepril.HCl (CGS 14 824 A) in healthy volunteers after single and repeated administration.
    Kaiser G; Ackermann R; Brechbühler S; Dieterle W
    Biopharm Drug Dispos; 1989; 10(4):365-76. PubMed ID: 2758102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentrations of an angiotensin-converting enzyme inhibitor, benazepril, and its active metabolite, benazeprilat, after repeated administrations of benazepril in dogs with experimental kidney impairment.
    Kitagawa H; Eguchi T; Kitoh K; Ohba Y; Kondo M; Nakano M; Sasaki Y
    J Vet Med Sci; 2000 Feb; 62(2):179-85. PubMed ID: 10720188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of benazepril, a new angiotensin-converting enzyme inhibitor, and its active metabolite, benazeprilat, in plasma and urine by capillary gas chromatography-mass-selective detection.
    Sioufi A; Pommier F; Kaiser G; Dubois JP
    J Chromatogr; 1988 Dec; 434(1):239-46. PubMed ID: 3243821
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetic/Pharmacodynamic Modeling of Renin-Angiotensin Aldosterone Biomarkers Following Angiotensin-Converting Enzyme (ACE) Inhibition Therapy with Benazepril in Dogs.
    Mochel JP; Fink M; Peyrou M; Soubret A; Giraudel JM; Danhof M
    Pharm Res; 2015 Jun; 32(6):1931-46. PubMed ID: 25446774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.